| Simultaneous quantification of 12 different nucleotides and nucleosides released from renal epithelium and in human urine samples using ion-pair reversed-phase HPLC A Contreras-Sanz, TS Scott-Ward, HS Gill, JC Jacoby, RE Birch, ... Purinergic signalling 8, 741-751, 2012 | 73 | 2012 |
| Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites BH Kaae, K Harpsøe, JS Kastrup, AC Sanz, DS Pickering, B Metzler, ... Chemistry & biology 14 (11), 1294-1303, 2007 | 71 | 2007 |
| TROP2 expression across molecular subtypes of urothelial carcinoma and enfortumab vedotin-resistant cells J Chou, K Trepka, M Sjöström, EA Egusa, CE Chu, J Zhu, E Chan, ... European urology oncology 5 (6), 714-718, 2022 | 52 | 2022 |
| Unravelling disparate roles of NOTCH in bladder cancer A Goriki, R Seiler, AW Wyatt, A Contreras-Sanz, A Bhat, A Matsubara, ... Nature Reviews Urology 15 (6), 345-357, 2018 | 51 | 2018 |
| Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors SSP Wildman, M Boone, CM Peppiatt-Wildman, A Contreras-Sanz, ... Journal of the American Society of Nephrology 20 (7), 1480-1490, 2009 | 50 | 2009 |
| 4-Hydroxy-1, 2, 5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic … ML Lolli, C Giordano, DS Pickering, B Rolando, KB Hansen, A Foti, ... Journal of medicinal chemistry 53 (10), 4110-4118, 2010 | 33 | 2010 |
| Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria A Contreras-Sanz, L Krska, AA Balachandran, NL Curtiss, R Khasriya, ... American Journal of Physiology-Renal Physiology 311 (4), F805-F816, 2016 | 31 | 2016 |
| A new phenylalanine derivative acts as an antagonist at the AMPA receptor GluA2 and introduces partial domain closure: Synthesis, resolution, pharmacology, and crystal structure E Szymanska, K Frydenvang, A Contreras-Sanz, DS Pickering, E Frola, ... Journal of medicinal chemistry 54 (20), 7289-7298, 2011 | 25 | 2011 |
| Assessment of predictive genomic biomarkers for response to cisplatin-based neoadjuvant chemotherapy in bladder cancer A Gil-Jimenez, J van Dorp, A Contreras-Sanz, K van der Vos, DJ Vis, ... European urology 83 (4), 313-317, 2023 | 23 | 2023 |
| Recent progress with next‐generation biomarkers in muscle‐invasive bladder cancer A Contreras‐Sanz, ME Roberts, R Seiler, PC Black International Journal of Urology 24 (1), 7-15, 2017 | 18 | 2017 |
| Paternally expressed gene 10 (PEG10) promotes growth, invasion, and survival of bladder cancer Y Kawai, K Imada, S Akamatsu, F Zhang, R Seiler, T Hayashi, J Leong, ... Molecular cancer therapeutics 19 (10), 2210-2220, 2020 | 13 | 2020 |
| Urinary ATP and visualization of intracellular bacteria: a superior diagnostic marker for recurrent UTI in renal transplant recipients? SP Kelley, HR Courtneidge, RE Birch, A Contreras-Sanz, MC Kelly, ... Springerplus 3, 1-7, 2014 | 11 | 2014 |
| Perspectives on the discovery of NOTCH2‐specific inhibitors P Dobranowski, F Ban, A Contreras‐Sanz, A Cherkasov, PC Black Chemical Biology & Drug Design 91 (3), 691-706, 2018 | 7 | 2018 |
| Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy M Roumiguie, A Contreras-Sanz, G Kumar, PC Black Nature Communications 12 (1), 4833, 2021 | 6 | 2021 |
| FBXW7 loss of function contributes to worse overall survival and is associated with accumulation of MYC in muscle invasive bladder cancer T Matumoto, Y Chen, A Contreras-Sanz, K Ikeda, G Schulz, J Gao, HZ Oo, ... Urologic Oncology: Seminars and Original Investigations 38 (12), 904-905, 2020 | 4 | 2020 |
| Uroplakin II as a single marker for luminal versus basal molecular subtypes in muscle invasive urothelial carcinoma C Pryma, C Villamil, EA Gibb, HZ Oo, R Seiler, A Contreras-Sanz, ... Virchows Archiv 481 (3), 397-403, 2022 | 3 | 2022 |
| Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine S Tsukahara, M Shiota, D Takamatsu, S Nagakawa, T Matsumoto, ... Scientific reports 12 (1), 8535, 2022 | 3 | 2022 |
| GRASP: GRAph-Structured Pyramidal Whole Slide Image Representation AK Mirabadi, G Archibald, A Darbandsari, A Contreras-Sanz, RE Nakhli, ... arXiv preprint arXiv:2402.03592, 2024 | 2 | 2024 |
| Classifying pulmonary and urinary high-grade neuroendocrine carcinoma by CK7 immunohistochemistry J Fan, H Li, C Zhou, W Xiong, C Villamil, D Ionescu, HZ Oo, ... Applied Immunohistochemistry & Molecular Morphology 30 (6), 459-468, 2022 | 2 | 2022 |
| Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy A Contreras-Sanz, GL Negri, M Reike, HZ Oo, J Scurll, SS Miko, K Nielsen, ... | | 2024 |
